Compare stocks
Market: US
TMOThermo Fisher Scientific
Add stock
Ticker or company
Summary

TMO
Thermo Fisher Scientific
$691,33Down −1,27%
Year: Up +21%
56/100★★★★★★★★Ratio would watch
Open stock pageTraffic light — 10 checks
| Check | TMO3 ✓ 3 — 2 ✕ |
|---|---|
| P/E vs its history | 36,3 |
| P/E vs industry | 36,3 |
| Forward P/E | 25,5 |
| Revenue growth, YoY | +8,3% |
| EPS growth, YoY | +9,5% |
| Net margin | n/a14,9% |
| Net debt / EBITDA | 3,6 |
| Free cash flow | $7,60 bn |
| Share count over a year | −1,9% |
| Cash runway | n/anot needed |
Metrics
Best WorstNo mark — in between
| Metric · better | TMOTTM | Industry medianTTM |
|---|---|---|
| P/E TTM ↓ | 36,3 | 37,9 |
| Forward P/E ↓ | 25,5 | 29,5 |
| PEG ↓ | 3,8 | 3,7 |
| P/S TTM ↓ | 5,4 | 6,6 |
| EV/EBITDA ↓ | 29,5 | 29,9 |
| P/FCF ↓ | 33,8 | 38,7 |
Price, %
- TMOn/a
Returns
Best WorstNo mark — in between
| Period | TMO |
|---|---|
| 1 year | n/a |
| 3 years | n/a |
| 5 years | n/a |
| All time | n/a |
“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.
Analysts and insiders
Best WorstNo mark — in between
| TMO | |
|---|---|
| Share of “buy” | 79% |
| Beat the forecast | 4 of 4 |
| Average “surprise” | +2,9% |
| Insiders over 12 months | sales $135 m |
Details are on each stock page.